BusinessCatalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 14, 2018, 8:13 PM UTC
BusinessArbutus Announces Corporate Update and Year-End 2017 Financial ResultsBy Nasdaq OMXMar 14, 2018, 8:00 PM UTC
BusinessBioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business DevelopmentBy Nasdaq OMXMar 13, 2018, 10:16 PM UTC
BusinessXeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei PharmaBy Nasdaq OMXMar 13, 2018, 9:00 PM UTC
BusinessCrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology AgentsBy Nasdaq OMXMar 13, 2018, 12:00 PM UTC
BusinessRadius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) InjectionBy Nasdaq OMXMar 12, 2018, 8:30 PM UTC
BusinessCrinetics Pharmaceuticals Announces Upcoming Presentations at ENDO 2018By Nasdaq OMXMar 12, 2018, 8:06 PM UTC
BusinessNewLink Genetics to Participate in Upcoming Investor ConferencesBy Nasdaq OMXMar 12, 2018, 1:01 PM UTC
